AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Evaluation of the Safety Plan to Prevent Suicidal Reiteration

RecruitingNAAges 18 Years - 65 YearsAllHรดpital le Vinatier
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Each year, suicide is the cause of 8,580 deaths in France, it is the second leading cause of death among 15-24 year olds. People who have made a first suicide attempt are identified as being at greater risk of repeating a suicidal gesture, particularly in the first month following the gesture . At the same time, Brief Intervention Contact (BIC) is recognized as effective in reducing suicide deaths. A new brief intervention to prevent suicidal attempts has been developed in the United States by Santley \& Brown (2012) the results of its effectiveness are very encouraging. Investigators hypothesise that the implementation of a safety plan by the emergency department for suicidal patients included in the Vigilans system leads to a greater reduction in the reiteration of suicidality at 6 months compared to the usual management. Our main objective is to evaluate the effectiveness of the im

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * 18 years of age or older * Seen in an emergency department * Admitted in emergency department following a suicide attempt \<48h * whose duration of care does not exceed 24 hours * For whom the care project results in a return home, * Who agree to be included in the Vigilans system * Who have social security coverage * Fluent in French Exclusion Criteria: * Refusal to participate in the study * Refusal to be accompanied by the Vigilans system * Hospitalisation for more than 24 hours in the immediate aftermath of the suicide attempt * Under protective measures.
๐Ÿ’Š

What it tests

  • As usual
  • Protection plan
๐Ÿ“

Where

1 site
Centre Hospitalier Le Vinatier
Bron, France
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy